Compare WKSP & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WKSP | OSRH |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 18.4M |
| IPO Year | N/A | N/A |
| Metric | WKSP | OSRH |
|---|---|---|
| Price | $1.97 | $0.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.25 | N/A |
| AVG Volume (30 Days) | 158.8K | ★ 2.9M |
| Earning Date | 11-13-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,286,679.00 | N/A |
| Revenue This Year | $142.95 | N/A |
| Revenue Next Year | $109.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 123.37 | N/A |
| 52 Week Low | $1.85 | $0.45 |
| 52 Week High | $11.00 | $11.84 |
| Indicator | WKSP | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 46.39 |
| Support Level | $1.85 | $0.69 |
| Resistance Level | $2.10 | $0.84 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 19.60 | 21.00 |
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.